Literature DB >> 25105306

Treatment preference, adherence and outcomes in patients with cancer: literature review and development of a theoretical model.

Sarah L Shingler1, Bryan M Bennett, Joyce A Cramer, Adrian Towse, Christopher Twelves, Andrew J Lloyd.   

Abstract

OBJECTIVE: A patient's preference may guide their behavior and influence their willingness to take medication or undergo treatment affecting outcomes, such as health-related quality of life, or survival. The importance of understanding patient preferences within oncology is unclear and few adherence studies exist compared with other therapeutic areas. RESEARCH DESIGN AND METHODS: This study was designed to review the literature regarding patient preferences, adherence and their link to outcomes specifically in the oncology setting and to propose a theoretical model. An in-depth review was conducted, using Embase, MEDLINE and Cochrane Library databases to search for published data examining patient preference, adherence and oncology-specific outcomes, from 1982-2012. Articles were reviewed independently by two authors and rated for relevance and quality. Information from high-quality articles and discussion with oncology and patient preference experts were used to identify associations between important individual concepts as a basis for a theoretical model.
RESULTS: In total, 1362 abstracts were identified. After removal of duplicates and initial review, 1269 were excluded and 93 reviewed in detail. Of these publications, 18 were deemed 'high-quality' and used to develop the final model. Variables associated with patient preference, adherence and outcome were identified. External variables included communication, treatment and mode of administration; patient beliefs and values were identified as cognitive variables; and adherence was attributed as a behavioral variable. Relationships between patient preference, adherence and clinical outcomes were established. Adverse events had a strong relationship with adherence; patient beliefs and values were identified as having a moderating effect on adherence. Adherence behavior had a direct relationship to outcomes.
CONCLUSIONS: Improving our understanding of patient preference may improve clinical outcomes in oncology patients. Although the proposed theoretical model is limited, it provides a basis to develop testable hypotheses for the relationships between patient preference, adherence and outcomes specific to oncology.

Entities:  

Keywords:  Adherence; Oncology; Outcomes; Patient preference; Theoretical model

Mesh:

Year:  2014        PMID: 25105306     DOI: 10.1185/03007995.2014.952715

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  19 in total

Review 1.  Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.

Authors:  Roberto Romero; Offer Erez; Maik Hüttemann; Eli Maymon; Bogdan Panaitescu; Agustin Conde-Agudelo; Percy Pacora; Bo Hyun Yoon; Lawrence I Grossman
Journal:  Am J Obstet Gynecol       Date:  2017-06-12       Impact factor: 8.661

2.  Factors that shape preference for acupuncture or cognitive behavioral therapy for the treatment of insomnia in cancer patients.

Authors:  Sheila N Garland; Whitney Eriksen; Sarah Song; Joshua Dearing; Frances K Barg; Philip Gehrman; Jun J Mao
Journal:  Support Care Cancer       Date:  2018-02-08       Impact factor: 3.603

3.  Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis.

Authors:  Mostafa R Mohamed; Erika Ramsdale; Kah Poh Loh; Asad Arastu; Huiwen Xu; Spencer Obrecht; Daniel Castillo; Manvi Sharma; Holly M Holmes; Ginah Nightingale; Katherine M Juba; Supriya G Mohile
Journal:  Oncologist       Date:  2019-09-30

4.  Cost-Effectiveness of Constraint-Induced Movement Therapy Implementation in Neurorehabilitation: The ACTIveARM Project.

Authors:  Lauren J Christie; Nicola Fearn; Annie McCluskey; Meryl Lovarini; Reem Rendell; Alison Pearce
Journal:  Pharmacoecon Open       Date:  2022-03-22

5.  The development of PubMed search strategies for patient preferences for treatment outcomes.

Authors:  Ralph van Hoorn; Wietske Kievit; Andrew Booth; Kati Mozygemba; Kristin Bakke Lysdahl; Pietro Refolo; Dario Sacchini; Ansgar Gerhardus; Gert Jan van der Wilt; Marcia Tummers
Journal:  BMC Med Res Methodol       Date:  2016-07-29       Impact factor: 4.615

6.  A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands.

Authors:  Marcus J Drake; Sally Bowditch; Emilio Arbe; Zalmai Hakimi; Florent Guelfucci; Ikbel Amri; Jameel Nazir
Journal:  BMC Urol       Date:  2017-05-22       Impact factor: 2.264

7.  Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).

Authors:  Merel L Kimman; Adrienne H Rotteveel; Marlies Wijsenbeek; Rémy Mostard; Nelleke C Tak; Xana van Jaarsveld; Marjolein Storm; Kioa L Wijnsma; Marielle Gelens; Nicole C A J van de Kar; Jack Wetzels; Carmen D Dirksen
Journal:  Patient       Date:  2017-10       Impact factor: 3.883

8.  Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment.

Authors:  Won-Il Choi; Jiah Choi; Mi-Ae Kim; Gyumin Lee; Jihyeon Jeong; Choong Won Lee
Journal:  Cancer Res Treat       Date:  2018-12-31       Impact factor: 4.679

9.  A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain.

Authors:  Jameel Nazir; Zalmai Hakimi; Florent Guelfucci; Amine Khemiri; Francis Fatoye; Ana María Mora Blázquez; Marta Hernández González
Journal:  BMC Urol       Date:  2018-09-04       Impact factor: 2.264

10.  Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire.

Authors:  Merel L Kimman; Marlies S Wijsenbeek; Sander M J van Kuijk; Kioa L Wijnsma; Nicole C A J van de Kar; Marjolein Storm; Xana van Jaarsveld; Carmen D Dirksen
Journal:  Patient       Date:  2019-02       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.